Do All Patients with Multiple Sclerosis Benefit from the Use of Contrast on Serial Follow-Up MR Imaging? A Retrospective Analysis.

Raghav R Mattay K Davtyan Michel Bilello A C Mamourian

Published in: AJNR. American journal of neuroradiology (2018)

Because all enhancing lesions were associated with new lesions on unenhanced imaging and progression was only evident in 24% of patients, in patients with relapsing-remitting MS, it is reasonable to consider reserving contrast for only those patients with evidence of progression on noncontrast MR images.

Keyphrases

multiple sclerosis
contrast enhanced
magnetic resonance
end stage renal disease
ejection fraction
newly diagnosed
mass spectrometry
high resolution
prognostic factors
deep learning
peritoneal dialysis
magnetic resonance imaging
disease activity
convolutional neural network
ms ms
photodynamic therapy